scholarly journals Addressing decreasing blood lead screening rates in young children in Broken Hill, NSW

2008 ◽  
Vol 19 (10) ◽  
pp. 180 ◽  
Author(s):  
Katina Kardamanidis ◽  
David M. Lyle ◽  
Frances Boreland
2006 ◽  
Vol 359 (1-3) ◽  
pp. 111-119 ◽  
Author(s):  
D.M. Lyle ◽  
A.R. Phillips ◽  
W.A. Balding ◽  
H. Burke ◽  
D. Stokes ◽  
...  

2004 ◽  
Vol 119 (2) ◽  
pp. 141-143 ◽  
Author(s):  
Embry M. Howell ◽  
Loretta Russette

PEDIATRICS ◽  
1994 ◽  
Vol 93 (2) ◽  
pp. 201-204
Author(s):  
Birt Harvey

In October 1991, the Centers for Disease Control and Prevention (CDC) recommended blood lead (BPb) screening for virtually all 1-year-old children and, preferably, for all 2-year-old children as well.1 In April 1993, the US Department of Health and Human Services distributed guidelines recommending that all newborns, regardless of race or ethnicity, be screened for sickle cell anemia.2 In June 1993, the National Institutes of Health issued a consensus conference recommendation that all infants be tested for hearing impairment within the first 3 months of life, preferably before newborns leave the hospital.3 In each instance, these screening recommendations were developed because a group of experts, after identifying a child health problem within its area of interest, believed that universal screening was indicated.


2002 ◽  
Vol 26 (3) ◽  
pp. 203-207 ◽  
Author(s):  
F. Boreland ◽  
DM. Lyle ◽  
J. Wlodarczyk ◽  
W.A. Balding ◽  
S. Reddan

PEDIATRICS ◽  
1994 ◽  
Vol 94 (3) ◽  
pp. 410-410
Author(s):  
Birt Harvey

Needleman and other distinguished investigators of lead toxicity raise three issues. 1. Whether lead is a neurotoxin. Here there is full agreement. As I stated in my editorial, "Lead is a poison, and the less of it in the bodies of growing children the better."1 Adverse effects in young children possibly may occur at blood lead (BPb) levels <10 µg/dL However, neither the epidemiologic studies cited by Needleman and colleagues nor any references I could find demonstrate that BPb <20 µg/dL at age I year causes a clinically important decrease in intelligence or an increase in neurobehavioral problems by the time a child enters school.


1995 ◽  
Vol 41 (3) ◽  
pp. 469-470 ◽  
Author(s):  
K Verebey ◽  
J F Rosen ◽  
D J Schonfeld ◽  
D Carriero ◽  
Y M Eng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document